Skip to main content
EJNMMI Reports

Table 1 PET-CT outcome and pathological characteristics of biopsies for all the patients (TZ = transition zone; PZ = peripheral zone)

From: Targeted 11C–choline PET-CT/TRUS software fusion-guided prostate biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy

Case

Site

SUVmax

SUVbackground

Core(+)/Total core

Diagnosis

Gleason score

Tumor volume mm(+)/mm tot (%)

1

Right lobe (TZ)

4,93

3

0/2

BPH

–

–

Left lobe (PZ)

7,18

2,86

0/2

Prostatitis

–

–

Left lobe (TZ)

6,4

2,9

0/1

BPH

–

–

2

Right lobe (TZ)

5,79

3,66

6/6

Ca

5 + 4

80/84 (95%)

3

Right lobe (PZ)

5,7

4,09

0/1

BPH

–

–

Left lobe (TZ)

5,7

2,94

0/1

BPH

–

–

Right lobe (TZ)

5,83

4,36

0/1

BPH

–

–

4

Right lobe (TZ)

4,6

3,48

0/2

BPH

–

–

Left lobe (TZ)

5,07

3,3

0/3

BPH

–

–

5

Left lobe (TZ)

1,9

1,63

–

NO BX

–

–

6

Right lobe (TZ)

7,02

3,43

6/7

Ca

4 + 3

31/83 (37,3%)

7

Left lobe (TZ)

4,01

2,75

3/3

Ca

3 + 3

1,5/31 (4,3%)

Left lobe (TZ)

4,54

2,75

0/1

BPH

–

–

8

Right lobe (TZ)

3,71

2,61

2/3

Ca

3 + 3

9/24 (37%)

Left lobe (TZ)

3,38

2,61

0/4

BPH

–

–

9

Right lobe (PZ)

3.74

2.4

6/8

Ca

3 + 5

90,5/114 (79,4%)

10

Right lobe (TZ)

5,52

3,92

0/3

BPH

–

–

Left lobe (TZ)

6,31

2,97

0/3

BPH

–

–

11

Right lobe (TZ)

4.64

2.97

0/2

BPH

–

–

Left lobe (TZ)

4.81

2.97

0/2

BPH

–

–

Left lobe (TZ)

5.22

2.97

0/2

BPH

–

–

12

Left lobe (TZ)

5.11

3.35

1/2

Ca

3 + 4

4/24 (16,7%)

13

Right lobe (PZ)

6.17

2.92

0/2

BPH

–

–

Left lobe (TZ)

6.51

2.92

0/6

BPH

–

–

14

Left lobe (TZ)

6.68

5.54

0/1

BPH

–

–

Left lobe (PZ)

7.91

5.54

0/2

BPH

–

–

Right lobe (TZ)

8.33

5.54

0/5

BPH

–

–

15

Right lobe (TZ)

4

2

0/4

BPH

–

–

Right lobe (PZ)

4.18

2

0/4

BPH

–

–

Left lobe (TZ)

4.33

2

1/4

Ca

3 + 3

1,1/52 (2,1%)

Left lobe (PZ)

3.32

2

0/4

BPH

–

–

Back to article page